plateaued on tirzepatide Why Weight Loss Plateaus Semaglutide or Plateau? Ineffective Formula? Or me?

This is a normal, expected part of the titration process, not a sign that the medication is failing

The subsequent dose should then be taken on the regularly scheduled day

Keywords: adjusted indirect treatment comparison, GIP/GLP1 receptor agonist, incretin mimetic, incretins, matchingadjusted indirect comparison, semaglutide, tirzepatide, type 2 diabetes 1

IVIM Health compared to other tirzepatide providers Context matters

While those medications target the GLP-1 (glucagon-like peptide-1) receptor, Tirzepatide is classified as a dual agonist, meaning it acts on both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor

Common negative reports include increased injection site discomfort, slightly more GI upset (particularly during the first few weeks), and disappointment when the dramatic results promised by marketing materials do not materialize